back-pain
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Xopenex to manage bronchospasm. In addition, warned of possible S/E such as dizziness, migraine, pain, tremor, anxiety, tachycardia, dyspepsia, leg cramps, increased cough, flu syndrome, accidental injury and viral infection.
Instructed to recognize S/S of Rheumatoid arthritis such as loss of appetite, fatigue, weakness, pain and tenderness of joint, weight loss, swelling, etc.
Instructed in measures to control rheumatoid arthritis such as adequate exercise, proper diet, stress control, pain control, physical or occupational therapy, self-help devices, emotional support and others.
Instructed in recognizing signs and symptoms of angina pectoris such as chest pain, anxiety, indigestion, sweating and shortness of breath.
Instructed in signs and symptoms of possible complication of Foley Catheter such as urinary tract infection (symptoms include cloudy urine, foul odor, fever and pain in bladder area), blocked catheter, bleeding, leaking, and bladder spasms.
Instructed in signs and symptoms of osteoarthritis such as aching pain that increases with activity and is usually relieved with rest, stiffness upon rising, heberdens nodes, fatigue, decreased exercise tolerance, crepitus, restriction of joint movement and others.
Instructed in S/S of possible complication due to Foley Catheter removed such as bleeding, fever, urine sediment, bladder distention, pain, burning, etc. Instructed to report any of these S/S.
Instructed in new medication Pred Forte to manage inflammation of palpebral and bulbar conjunctiva, cornea and anterior segment of globe. In addition, warned of possible S/E, such as, increased intraocular pressure, thinning of cornea, interference with corneal wound healing, increased susceptibility to viral or fungal corneal infections, corneal ulceration, discharge, discomfort, foreign body sensation, glaucoma exacerbation, cataracts, visual acuity and visual field defects, optic nerve damage with excessive or long-term use, systemic effects, and adrenal suppression with excessive or long-term use. Instructed to wash hands before and after installation and warned not to touch tip of dropper to eye or surrounding area. Apply light finger pressure on lacrimal sac for 1 minute after installation. On long-term therapy, have frequent tests of intraocular pressure. Instructed not to share drug, washcloths, or towels with family members, and notify MD if anyone develops same signs or symptoms. Stress importance of compliance with recommended therapy. Notify MD if improvement does not occur within several days or if pain, itching, or swelling of eye occurs. Instructed not to use leftover drug for new eye inflammation because serious problems may occur.
Instructed in visiting an ophthalmologist, an MD who specializes in eye care inmediately if there are any of these symptoms of eye damage: blurred or double vision, narrowed field of vision, seeing dark spots, feeling of pressure or pain in the eyes and difficulty seeing in dim light.